Literature DB >> 11104816

Cytopathogenesis and inhibition of host gene expression by RNA viruses.

D S Lyles1.   

Abstract

Many viruses interfere with host cell function in ways that are harmful or pathological. This often results in changes in cell morphology referred to as cytopathic effects. However, pathogenesis of virus infections also involves inhibition of host cell gene expression. Thus the term "cytopathogenesis," or pathogenesis at the cellular level, is meant to be broader than the term "cytopathic effects" and includes other cellular changes that contribute to viral pathogenesis in addition to those changes that are visible at the microscopic level. The goal of this review is to place recent work on the inhibition of host gene expression by RNA viruses in the context of the pathogenesis of virus infections. Three different RNA virus families, picornaviruses, influenza viruses, and rhabdoviruses, are used to illustrate common principles involved in cytopathogenesis. These examples were chosen because viral gene products responsible for inhibiting host gene expression have been identified, as have some of the molecular targets of the host. The argument is made that the role of the virus-induced inhibition of host gene expression is to inhibit the host antiviral response, such as the response to double-stranded RNA. Viral cytopathogenesis is presented as a balance between the host antiviral response and the ability of viruses to inhibit that response through the overall inhibition of host gene expression. This balance is a major determinant of viral tissue tropism in infections of intact animals.

Entities:  

Mesh:

Year:  2000        PMID: 11104816      PMCID: PMC99011          DOI: 10.1128/MMBR.64.4.709-724.2000

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  141 in total

1.  The cytoskeletal framework and poliovirus metabolism.

Authors:  R Lenk; S Penman
Journal:  Cell       Date:  1979-02       Impact factor: 41.582

2.  Transcription of vesicular stomatitis virus is required to shut off cellular RNA synthesis.

Authors:  P K Weck; R R Wagner
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

3.  Analysis of VSV mutant with attenuated cytopathogenicity: mutation in viral function, P, for inhibition of protein synthesis.

Authors:  C P Stanners; A M Francoeur; T Lam
Journal:  Cell       Date:  1977-06       Impact factor: 41.582

4.  Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway.

Authors:  S Balachandran; P C Roberts; T Kipperman; K N Bhalla; R W Compans; D R Archer; G N Barber
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  [Genetic study of vesicular stomatitis virus: classification of spontaneous thermosensitive mutants into complementation groups].

Authors:  A Flamand
Journal:  J Gen Virol       Date:  1970-09       Impact factor: 3.891

6.  Inhibition of ribonucleic acid accumulation in mouse L cells infected with vesicular stomatitis virus requires viral ribonucleic acid transcription.

Authors:  F S Wu; J M Lucas-Lenard
Journal:  Biochemistry       Date:  1980-02-19       Impact factor: 3.162

7.  Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus.

Authors:  R R Wagner; A S Huang
Journal:  Virology       Date:  1966-01       Impact factor: 3.616

8.  Vesicular stomatitis virus infection reduces the number of active DNA-dependent RNA polymerases in myeloma cells.

Authors:  P K Weck; R R Wagner
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

9.  Translational control of protein synthesis after infection by vesicular stomatitis virus.

Authors:  H F Lodish; M Porter
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

10.  Interferon production and inhibition of host synthesis in cells infected with vesicular stomatitis virus.

Authors:  G W Wertz; J S Youngner
Journal:  J Virol       Date:  1970-10       Impact factor: 5.103

View more
  77 in total

1.  Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus.

Authors:  S A Kopecky; M C Willingham; D S Lyles
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 2.  Plasticity in programming of effector and memory CD8 T-cell formation.

Authors:  Ramon Arens; Stephen P Schoenberger
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

3.  Diverse roles for E4orf3 at late times of infection revealed in an E1B 55-kilodalton protein mutant background.

Authors:  Robin N Shepard; David A Ornelles
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

4.  Immunogenicity of cytopathic and noncytopathic viral vectors.

Authors:  Gabriela Plesa; Philip M McKenna; Matthias J Schnell; Laurence C Eisenlohr
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Vesicular stomatitis virus induces apoptosis in the Wong-Kilbourne derivative of the Chang conjunctival cell line.

Authors:  Eva Gallyas; György Seprényi; Eniko Sonkoly; Yvette Mándi; Lajos Kemény; Klára Megyeri
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-11-19       Impact factor: 3.117

6.  Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma.

Authors:  Y A Bochkov; K M Hanson; S Keles; R A Brockman-Schneider; N N Jarjour; J E Gern
Journal:  Mucosal Immunol       Date:  2009-08-26       Impact factor: 7.313

7.  Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.

Authors:  John H Connor; Douglas S Lyles
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway.

Authors:  Gourapura J Renukaradhya; Masood A Khan; Daniel Shaji; Randy R Brutkiewicz
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

9.  Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.

Authors:  Cassandra L Braxton; Shelby H Puckett; Steven B Mizel; Douglas S Lyles
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

10.  A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein.

Authors:  Wataru Kamitani; Cheng Huang; Krishna Narayanan; Kumari G Lokugamage; Shinji Makino
Journal:  Nat Struct Mol Biol       Date:  2009-10-18       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.